How To Be An Early-Stage Biotech CEO In Challenging Times

Next Generation Leaders Share Their Lessons

The ongoing downturn is making early-stage biotech leaders work harder to gain funding – but new technology, business focus and better working practices could help them achieve success. 

A chess king last stand as a true winner.Money game concept. Copy space.

While we are unquestionably living in a golden age for biopharma drug discovery and development, 2023 is also proving a tough time to be an early-stage biotech company.

That is because the ‘easy money’ days of 2021 have evaporated, and many start-ups launched in the boom times now...

More from C-Suite Speaks

More from Leadership